Teleflex Incorporated (TFX)
NYSE: TFX · Real-Time Price · USD
118.41
+2.92 (2.53%)
At close: Aug 8, 2025, 4:00 PM
118.69
+0.28 (0.24%)
After-hours: Aug 8, 2025, 7:53 PM EDT
Paramount Global Revenue
Teleflex had revenue of $780.89M in the quarter ending June 29, 2025, with 4.16% growth. This brings the company's revenue in the last twelve months to $3.04B, up 1.11% year-over-year. In the year 2024, Teleflex had annual revenue of $3.05B with 2.45% growth.
Revenue (ttm)
$3.04B
Revenue Growth
+1.11%
P/S Ratio
1.78
Revenue / Employee
$215,698
Employees
14,100
Market Cap
5.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.05B | 72.84M | 2.45% |
| Dec 31, 2023 | 2.97B | 183.45M | 6.57% |
| Dec 31, 2022 | 2.79B | -18.52M | -0.66% |
| Dec 31, 2021 | 2.81B | 272.41M | 10.74% |
| Dec 31, 2020 | 2.54B | -58.21M | -2.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
TFX News
- 8 days ago - Teleflex Incorporated (TFX) Q2 2025 Earnings Conference Call Transcript - Seeking Alpha
- 9 days ago - Teleflex Announces Quarterly Dividend - GlobeNewsWire
- 9 days ago - Teleflex Reports Second Quarter Financial Results and Full Year 2025 Outlook - GlobeNewsWire
- 14 days ago - Chest Drainage Catheters Market Insights, Competitive Landscape, and Forecast Report 2025-2032 Featuring Leading Players - BD, Teleflex, Cook, ICU Medical, and Redax - GlobeNewsWire
- 23 days ago - Teleflex Announces Second Quarter 2025 Earnings Conference Call Information - GlobeNewsWire
- 5 weeks ago - Teleflex Completes Acquisition of BIOTRONIK's Vascular Intervention Business - GlobeNewsWire
- 2 months ago - New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients - GlobeNewsWire
- 2 months ago - Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men's Health Month - GlobeNewsWire